We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$82.4B
AUM Growth
+$4.64B
Cap. Flow
-$1.97B
Cap. Flow %
-2.39%
Top 10 Hldgs %
8.31%
Holding
3,827
New
42
Increased
1,697
Reduced
793
Closed
1,164

Sector Composition

Rank Sector Weight
1 Technology 16.42%
2 Financials 14.42%
3 Industrials 12.17%
4 Healthcare 10.62%
5 Consumer Discretionary 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FENC icon
2576
Fennec Pharmaceuticals
FENC
$402M
$41K ﹤0.01%
6,338
-3,009
-32% -$16.2K
AKRX
2577
DELISTED
Akorn Inc
AKRX
$41K ﹤0.01%
27,267
+11,178
+69% +$42.2K
STRO icon
2578
Sutro Biopharma
STRO
$421M
$40K ﹤0.01%
366
-178
-33% -$18.4K
XLI icon
2579
State Street Industrial Select Sector SPDR ETF
XLI
$34.6B
$39K ﹤0.01%
483
CBAN icon
2580
Colony Bankcorp
CBAN
$467M
$37K ﹤0.01%
2,215
-1,385
-38% -$21.9K
AKRO
2581
DELISTED
Akero Therapeutics
AKRO
$36K ﹤0.01%
1,608
-1,021
-39% -$21.1K
CTO
2582
CTO Realty Growth
CTO
$815M
$24K ﹤0.01%
1,455
-3,135
-68% -$54.1K
LOGC
2583
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$22K ﹤0.01%
3,000
-3,200
-52% -$28.9K
NWS icon
2584
News Corp Class B
NWS
$17.5B
$21K ﹤0.01%
1,473
-51
-3% -$703
STIM icon
2585
Neuronetics
STIM
$166M
$18K ﹤0.01%
3,996
-1,747
-30% -$10.9K
BXRX
2586
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$15K ﹤0.01%
+2
New +$17.1K
FOMX
2587
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$14K ﹤0.01%
4,125
LCNB icon
2588
LCNB Corp
LCNB
$283M
$4K ﹤0.01%
209
-17
-8% -$311
GMDA
2589
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$4K ﹤0.01%
1,000
BNGOW
2590
DELISTED
Bionano Genomics, Inc. Warrant
BNGOW
$3K ﹤0.01%
8,136
EQS icon
2591
Equus Total Return
EQS
$16.8M
$2K ﹤0.01%
1,196
-20
-2% -$32
DCOY
2592
Decoy Therapeutics
DCOY
$2.09M
0
AAME icon
2593
Atlantic American Corp
AAME
$31.2M
-901
Closed -$2K
AAOI icon
2594
Applied Optoelectronics
AAOI
$11.5B
-3,087
Closed -$35K
ABEO icon
2595
Abeona Therapeutics
ABEO
$413M
-188
Closed -$11K
AC
2596
DELISTED
Associated Capital Group
AC
-572
Closed -$20K
ACET icon
2597
Adicet Bio
ACET
$74.7M
-25
Closed -$25K
ACHV icon
2598
Achieve Life Sciences
ACHV
$683M
-70
Closed -$2K
ACMR icon
2599
ACM Research
ACMR
$5.79B
-1,119
Closed -$5K
ACNT icon
2600
Ascent Industries
ACNT
$141M
-1,453
Closed -$23K

Similar funds

Victory Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Victory Capital Management held 3,827 positions worth $82.4B, up 6% from $77.7B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.

Victory Capital Management's Q4 2019 filing shows 42 new, 1,697 increased, 793 reduced and 1,164 closed positions. Its largest new stake was iShares MSCI Japan ETF: 2,110,657 shares worth $125M. The largest sale was Tiffany & Co., an estimated $271M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Industrials.

  • Victory Capital Management's largest Q4 2019 buy was iShares MSCI Japan ETF: 2,110,657 shares worth $125M.
  • Victory Capital Management added most to Vanguard S&P 500 ETF in Q4 2019, an estimated $263M increase.
  • Victory Capital Management's biggest Q4 2019 reduction was Tiffany & Co., cutting an estimated $271M.
  • Victory Capital Management fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $220M.
  • Victory Capital Management's ten largest holdings make up 8.3% of its $82.4B portfolio in Q4 2019.
  • Victory Capital Management opened 42 new positions and closed 1,164 in Q4 2019.
  • Victory Capital Management's portfolio value rose 6% quarter-over-quarter to $82.4B.

Based on Victory Capital Management's 13F filing for Q4 2019, filed 4 Feb 2020.